beta
Trial Radar AI
Clinical Trial NCT07320157 (HPV-Education) for HPV (Human Papillomavirus)-Associated, HPV Immunization Status is recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake (HPV-Education) 64 Observational

Recruiting
Clinical Trial NCT07320157 (HPV-Education) is an interventional study for HPV (Human Papillomavirus)-Associated, HPV Immunization Status that is recruiting. It started on January 9, 2026 with plans to enroll 64 participants. Led by Ufuk University, it is expected to complete by April 3, 2026. The latest data from ClinicalTrials.gov was last updated on January 22, 2026.
Brief Summary
Type of Study: This study was planned to be an observational study.

Purpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question\[s\] it aims to answer \[is/are\]:

H1: There is a difference in the mean Human Papillomavirus (HPV) Knowledge Scale score between the intervention group women who participated in Human Papillomav...

Show More
Official Title

"Women's HPV Education and Its Effects on Knowledge Levels, HPV Screening Behaviors, and HPV Vaccination Uptake: An Interventional Education Study"

Conditions
HPV (Human Papillomavirus)-AssociatedHPV Immunization Status
Other Study IDs
  • HPV-Education
  • E-81182178-605-56406
NCT ID Number
NCT07320157
Start Date (Actual)
2026-01-09
Last Update Posted
2026-01-22
Completion Date (Estimated)
2026-04-03
Enrollment (Estimated)
64
Study Type
Interventional
PHASE
N/A
Status
Recruiting
Keywords
HPV
WOMEN
HEALTH
VACCİNE
Primary Purpose
Prevention
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
Participant Group/ArmIntervention/Treatment
ExperimentalOnline Education Intervention Group
An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after deli...Show More
Online Education Intervention Group
An online training session will be scheduled for the intervention group. The training will consist of two 40-minute session. After the online training, the training materials will be shared with the group. One week after the training, an informational brochure prepared on the topic will be sent to the intervention group via WhatsApp as a reminder, and any questions they may have will be answered. Two weeks after deli...Show More
Contral Group
No intervention will be applied to the control group. Following the completion of the study, the brochure prepared on the topic will be sent to them via WhatsApp.
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Change in HPV Knowledge Score
Change in participants' HPV Knowledge Scale scores measured at baseline, first follow-up, and final follow-up. The measure evaluates the effect of the online education and brochure intervention compared to the control group.
Baseline (before intervention), 2 weeks after brochure delivery (first follow-up), and 8 weeks after the first follow-up (final follow-up)
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Sustained HPV Knowledge Score (Knowledge Retention)
Final follow-up (8 weeks after the first follow-up)
Knowledge retention will be assessed by comparing HPV Knowledge Scale scores between groups at the final follow-up. Higher scores indicate better long-term retention of information provided by the intervention.
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult
Minimum Age
18 Years
Eligible Sexes
Female
Accepts Healthy Volunteers
Yes
  • Being female
  • Women aged 18-35 years
  • Ability to speak and understand Turkish at a level sufficient to communicate with the researcher
  • Having the technical equipment necessary to participate in a video interview
  • No diagnosis of HPV positivity
  • Not having received the HPV vaccine
  • Not having undergone HPV DNA/Pap smear testing in the past 5 years
  • No diagnosis of cervical cancer
  • Voluntary willingness to participate in the study
  • No diagnosis of a psychiatric disorder

  • Being male
  • Having severe physical or cognitive impairments that prevent completing the questionnaire
  • Being under 18 years of age or over 35 years of age
  • Inability to speak or understand Turkish
  • Lack of technical equipment to participate in a video interview
  • Having a diagnosis of HPV positivity
  • Having received the HPV vaccine
  • Having undergone HPV DNA/Pap smear testing in the past 5 years
  • Having a diagnosis of cervical cancer
  • Having a diagnosed psychiatric disorder

Not agreeing to participate in the study

Ufuk University logoUfuk University
Study Responsible Party
Gizem Bilmez, Principal Investigator, Principal Investigator, Ufuk University
Study Central Contact
Contact: GİZEM B BİLMEZ GİZEM, PHD STUDENT, 905532657387, [email protected]
Contact: Duygu Akçay, Assistant Professor (PhD), +905055947466, [email protected]
1 Study Locations in 1 Countries

Ankara

UfUk UNİVERSİTY, Ankara, Ankara, 06000, Turkey (Türkiye)
UFUK U BİLMEZ, GİZEM, Advanced Practice Nurse, Contact, 905532657387, [email protected]
Recruiting